Antibody Structure and Function: The Basis for Engineering Therapeutics.
Chiu ML, Goulet DR, Teplyakov A, Gilliland GL. · 2019
Read Antibody Structure and Function: The Basis for Engineering Therapeutics. by Chiu ML, Goulet DR, Teplyakov A, Gilliland GL. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6963682.txt.
Description
Chiu and co-authors review antibody structure as the base for engineering modern protein drugs. Their review appeared in Antibodies. Antibodies and their offshoots now anchor protein-based therapy. Knowing how their shape drives function lets engineers tailor binding strength, immune effects, and stability.
The authors start with basic antibody anatomy, then show how that knowledge powers design. Formats include full antibodies, fragments, two-armed bispecific molecules, and fusion products. Tuning steps cover humanization, strength adjustment, and stability fixes. They also discuss choosing binding arms and adjusting grip through avidity. Strategies for building multi-specific drugs for many uses fill the later sections. The goal throughout is drugs that work better and are easier to manufacture.
Catalog record
| CREATOR | Chiu ML, Goulet DR, Teplyakov A, Gilliland GL. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 340 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |